Action IGX INTELGENX TECHNOLOGIES CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues IntelGenx Technologies Corp. OTC Bulletin Board

Actions

IGX

US45822R1014

Cours en clôture OTC Bulletin Board
Autres places de cotation
- CAD - Graphique intraday de IntelGenx Technologies Corp.
17/05 IntelGenx Technologies Corp. annonce la démission de membres de son conseil d'administration CI
17/05 IntelGenx Technologies entame des procédures de restructuration en vertu de la LACC afin de mettre en œuvre un examen de ses options stratégiques CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
IntelGenx Reports Launch of Sale and Investment Solicitation Process
IntelGenx Announces Initiation of the Sale and Investment Solicitation Process
IntelGenx Brief: Says Obtained Court-Approval of a Sale and Investment Solicitation Process; Had Recently Initiated Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx Obtains Court-Approval of a Sale and Investment Solicitation Process
ATAI Life Sciences AG entered into an agreement of purchase and sale to acquire the Assets of IntelGenx Technologies Corp..
IntelGenx Begins Restructuring Proceedings Under CCAA to Implement Review of Strategic Alternatives
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx Brief: Initiating Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx Technologies Corp. Announces Board Resignations
Canadian Investment Regulatory Organization Trading Halt - IGX
IntelGenx Technologies Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx: Q1 Earnings Snapshot
IntelGenx Technologies Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
IntelGenx Announces Voting Results on Election of Directors
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
Intelgenx Announces First Parkinson?S Disease Patients Dosed with Montelukast Versafilm® in Phase 2 ?Montpark? Clinical Trial
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action IGXT
  4. Action IGX
  5. Actualités IntelGenx Technologies Corp.
  6. Autres langues